Australia markets closed

Teva Pharmaceutical Industries Limited (TEVJF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
8.700.00 (0.00%)
At close: 08:37AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 9.69B
Enterprise value 29.08B
Trailing P/E 900.00
Forward P/E 3.43
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.64
Price/book (mrq)1.10
Enterprise value/revenue 1.92
Enterprise value/EBITDA -2.91k

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 35.71%
S&P500 52-week change 3-15.73%
52-week high 311.95
52-week low 37.00
50-day moving average 38.52
200-day moving average 38.60

Share statistics

Avg vol (3-month) 317
Avg vol (10-day) 3N/A
Shares outstanding 51.11B
Implied shares outstanding 6N/A
Float 81.1B
% held by insiders 10.79%
% held by institutions 14.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 Nov 2017
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -8.53%
Operating margin (ttm)18.89%

Management effectiveness

Return on assets (ttm)3.88%
Return on equity (ttm)-12.45%

Income statement

Revenue (ttm)15.14B
Revenue per share (ttm)13.67
Quarterly revenue growth (yoy)-7.50%
Gross profit (ttm)7.59B
Net income avi to common (ttm)-1.29B
Diluted EPS (ttm)-0.56
Quarterly earnings growth (yoy)-80.80%

Balance sheet

Total cash (mrq)2.22B
Total cash per share (mrq)2
Total debt (mrq)21.62B
Total debt/equity (mrq)227.15
Current ratio (mrq)0.99
Book value per share (mrq)7.89

Cash flow statement

Operating cash flow (ttm)1.07B
Levered free cash flow (ttm)2.66B